Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data
Villanueva, Càndid Sapena, Victor Lo, Gin-Ho Seo, Yeon Seok Shah, Hasnain Ali Singh, Virendra Tripathi, Dhiraj Schepke, Michael Gheorghe, Cristian Bonilha, Daniell Q
Villanueva, Càndid
Sapena, Victor
Lo, Gin-Ho
Seo, Yeon Seok
Shah, Hasnain Ali
Singh, Virendra
Tripathi, Dhiraj
Schepke, Michael
Gheorghe, Cristian
Bonilha, Daniell Q
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2023-12-18
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Of 25 RCTs eligible, 14 failed to provide IPD and 11 were included, comprising 1400 patients (656 compensated, 744 decompensated), treated with NSBBs (N = 625), EVL (N = 546) or NSBB+EVL (N = 229). Baseline characteristics were similar between groups. Overall, mortality risk was similar with EVL vs. NSBBs (subdistribution hazard-ratio (sHR) = 1.05, 95% CI = 0.75-1.49) and with EVL + NSBBs vs either monotherapy, with low heterogeneity (I2 = 28.7%). In compensated patients, mortality risk was higher with EVL vs NSBBs (sHR = 1.76, 95% CI = 1.11-2.77) and not significantly lower with NSBBs+EVL vs NSBBs, without heterogeneity (I2 = 0%). In decompensated patients, mortality risk was similar with EVL vs. NSBBs and with NSBBs+EVL vs. either monotherapy.
Citation
Villanueva C, Sapena V, Lo GH, Seo YS, Shah HA, Singh V, Tripathi D, Schepke M, Gheorghe C, Bonilha DQ, Jutabha R, Wang HM, Rodrigues SG, Brujats A, Lee HA, Azam Z, Kumar P, Hayes PC, Sauerbruch T, Chen WC, Iacob S, Libera ED, Jensen DM, Alvarado E, Torres F, Bosch J; Baveno Cooperation-a EASL Consortium. Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data. Aliment Pharmacol Ther. 2024 Feb;59(3):306-321. doi: 10.1111/apt.17824. Epub 2023 Dec 18.
Type
Article